Resistencia antimicrobiana en Helicobacter pylori: aspectos clínicos y moleculares

Helicobacter pylori is a relevant pathogen for gastroduodenal diseases in human beings. Although its eradication often improves gastroduodenal diseases, H pylori is acquiring an elevated rate of resistance to various antimicrobials, such as metronidazole, clarithromycin, tetracycline and amoxicillin...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Vallejos M,Cristián, Cerda A,Oscar, Valenzuela V,Manuel, Toledo A,Héctor
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2003
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872003001100014
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872003001100014
record_format dspace
spelling oai:scielo:S0034-988720030011000142004-01-27Resistencia antimicrobiana en Helicobacter pylori: aspectos clínicos y molecularesVallejos M,CristiánCerda A,OscarValenzuela V,ManuelToledo A,Héctor Antibiotics combined Drug therapy combinations Helicobacter pylori Microbial sensitivity tests Helicobacter pylori is a relevant pathogen for gastroduodenal diseases in human beings. Although its eradication often improves gastroduodenal diseases, H pylori is acquiring an elevated rate of resistance to various antimicrobials, such as metronidazole, clarithromycin, tetracycline and amoxicillin. Multi-drug resistance is a major problem to select the appropriate treatment of infectious diseases. To improve our understanding on the com-plexity of the problem, in this article we review the resistance mechanisms and give an update on H pylori antimicrobial resistance (Rev Méd Chile 2003; 131: 1313-20)info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.131 n.11 20032003-11-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872003001100014es10.4067/S0034-98872003001100014
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Antibiotics
combined
Drug therapy
combinations
Helicobacter pylori
Microbial sensitivity tests
spellingShingle Antibiotics
combined
Drug therapy
combinations
Helicobacter pylori
Microbial sensitivity tests
Vallejos M,Cristián
Cerda A,Oscar
Valenzuela V,Manuel
Toledo A,Héctor
Resistencia antimicrobiana en Helicobacter pylori: aspectos clínicos y moleculares
description Helicobacter pylori is a relevant pathogen for gastroduodenal diseases in human beings. Although its eradication often improves gastroduodenal diseases, H pylori is acquiring an elevated rate of resistance to various antimicrobials, such as metronidazole, clarithromycin, tetracycline and amoxicillin. Multi-drug resistance is a major problem to select the appropriate treatment of infectious diseases. To improve our understanding on the com-plexity of the problem, in this article we review the resistance mechanisms and give an update on H pylori antimicrobial resistance (Rev Méd Chile 2003; 131: 1313-20)
author Vallejos M,Cristián
Cerda A,Oscar
Valenzuela V,Manuel
Toledo A,Héctor
author_facet Vallejos M,Cristián
Cerda A,Oscar
Valenzuela V,Manuel
Toledo A,Héctor
author_sort Vallejos M,Cristián
title Resistencia antimicrobiana en Helicobacter pylori: aspectos clínicos y moleculares
title_short Resistencia antimicrobiana en Helicobacter pylori: aspectos clínicos y moleculares
title_full Resistencia antimicrobiana en Helicobacter pylori: aspectos clínicos y moleculares
title_fullStr Resistencia antimicrobiana en Helicobacter pylori: aspectos clínicos y moleculares
title_full_unstemmed Resistencia antimicrobiana en Helicobacter pylori: aspectos clínicos y moleculares
title_sort resistencia antimicrobiana en helicobacter pylori: aspectos clínicos y moleculares
publisher Sociedad Médica de Santiago
publishDate 2003
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872003001100014
work_keys_str_mv AT vallejosmcristian resistenciaantimicrobianaenhelicobacterpyloriaspectosclinicosymoleculares
AT cerdaaoscar resistenciaantimicrobianaenhelicobacterpyloriaspectosclinicosymoleculares
AT valenzuelavmanuel resistenciaantimicrobianaenhelicobacterpyloriaspectosclinicosymoleculares
AT toledoahector resistenciaantimicrobianaenhelicobacterpyloriaspectosclinicosymoleculares
_version_ 1718436123076722688